Medication info

Gyro Tablet 10 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
IYUN Pharmaceutical Co., Ltd.
Appearance
Light yellow, biconvex, round film-coated tablet
Packaging
10 tablets/box [(10 tablets/PTP × 1)], 30 tablets/box [(10 tablets/PTP × 3)], 30 tablets/bottle
Approval status
Active

MFDS item code 202102286 · Approved 2021.03.12

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4, General Precautions).

Ingredients

Manufacturer
IYUN Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
  • cardiovascular disease
  • occurrence of cardiovascular events
View approved original text

This medication is used to help control blood sugar in adults with type 2 diabetes, in addition to diet and exercise. It can be administered alone, or if blood sugar control is insufficient, it may be used in combination with other diabetes medications such as metformin, pioglitazone, sulfonylureas, insulin, or linagliptin. Special caution is required by professionals when using this medication in type 2 diabetes patients with existing cardiovascular disease. It assists in diabetes management through effective blood sugar control.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4, General Precautions).

Precautions

This medication should not be used in patients with an allergy to the active ingredient or any other components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. It should not be used in patients with severely impaired kidney function, defined as a glomerular filtration rate of less than 30 mL/min/1.73m² or those with end-stage renal disease or on dialysis. This medication contains lactose, therefore it should not be administered to patients with lactose intolerance, galactose intolerance, or hereditary lactase deficiency. In patients with slightly impaired kidney function, careful monitoring is required, with potential need for dose adjustment or discontinuation during treatment. The use of this medication is not recommended in patients with severe heart failure, and caution should also be exercised in mild cases. When used in conjunction with insulin or insulin secretagogues, the risk of hypoglycemia may increase, necessitating potential dose reduction of these medications. While using this medication, individuals should be cautious of possible side effects such as hypoglycemia, genital infections, urinary tract infections, increased urination, and decreased fluid volume. Particularly, serious metabolic acidosis known as ketoacidosis may occur, and immediate treatment should be sought if symptoms appear; this medication should be discontinued. Elderly patients or those at risk of fluid volume depletion should be closely monitored for symptoms of dehydration and low blood pressure. This medication may increase the risk of serious infections such as urosepsis, pyelonephritis, and necrotizing fasciitis, necessitating prompt treatment for any signs of infection. Use during pregnancy is not recommended, and it should be discontinued if pregnancy is confirmed. Use during breastfeeding is also not recommended, thus breastfeeding should be stopped. The safety and efficacy of this medication in children under 18 have not been established. In case of overdose, appropriate treatment should be sought; there is no information on whether this medication can be removed by hemodialysis. Store this medication in a tightly sealed container away from children's reach and do not transfer to other containers. When driving or operating machinery, caution should be exercised considering the risk of hypoglycemia. Regular monitoring of kidney function, fluid status, and signs of infection during medication use is essential.

Side effects

  • Hypoglycemia
  • vulvovaginal candidiasis
  • balanitis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • ketoacidosis
  • pruritus
  • rash
  • urticaria
Show 221 more
  • angioedema
  • reduced fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • elevated serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ureteral stones
  • acute kidney injury
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • intestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • headache
  • orthostatic dizziness
  • sensory loss
  • paresthesia
  • amnesia
  • carotid artery stenosis
  • diabetic neuropathy
  • facial paralysis
  • intracranial aneurysm
  • memory impairment
  • neuralgia
  • Parkinson's disease
  • polyneuropathy
  • sensory disturbance
  • drowsiness
  • central nervous system origin vertigo
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • fever
  • facial swelling
  • chills
  • strange sensations
  • edema
  • pain
  • pain at the puncture site
  • vascular stent stenosis
  • vascular stent thrombosis
  • chest pain
  • fatigue
  • peripheral swelling
  • facial swelling
  • edema
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weight gain
  • abnormal electrocardiogram
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urinary red blood cells
  • ureteral stones
  • hematuria
  • renal mass
  • urinary retention
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vulvitis
  • cervicitis
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • lipoatrophy
  • diabetes
  • hyperlipidemia
  • hyponatremia
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • low back pain
  • limb pain
  • musculoskeletal chest pain
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • ocular discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal calcification
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid swelling
  • visual impairment
  • floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • cough
  • epistaxis
  • allergic rhinitis
  • limb injury
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • unstable angina
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • ear pain
  • orthostatic vertigo
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • diarrhea
  • dyspepsia
  • abdominal pain
  • nausea
  • gastritis
  • gastrointestinal disturbances
  • nasopharyngitis
  • shingles
  • dizziness
  • headache
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • low back pain
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow, biconvex, round film-coated tablet

Package unit

10 tablets/box [(10 tablets/PTP × 1)], 30 tablets/box [(10 tablets/PTP × 3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.